MORE►
remote drug monitoring
John Timberlake, president and CEO, Berkshire Biomedical [Dallas Innovates; Image Sources: Berkshire Biomedical]
Dallas’ Berkshire Biomedical Gets NIH Research Grant for Home Methadone Dispensing System
by David Seeley | Aug 2, 2022
Berkshire's COPA System delivers automated at-home methadone doses to treat people with opioid use disorder. The computerized device offers biometric screening and real-time remote monitoring as it "accurately and securely" dispenses the medication. This can help patients avoid having to travel to clinics and wait in line for their treatment—often every single day.
"These are people who want to get over their addiction," says president and CEO John Timberlake, who believes COPA can "help these patients maintain their jobs and get back into society."
